Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases

Gynecol Oncol. 2006 Sep;102(3):513-6. doi: 10.1016/j.ygyno.2006.01.010. Epub 2006 Feb 28.

Abstract

Objective: The aim of this study was to retrospectively evaluate, in a series of 16 consecutive patients, the technique, feasibility and oncological safety of laparoscopic anterior exenteration for locally advanced pelvic cancers.

Study design: Since August 2003, 16 patients with locally advanced pelvic cancer were considered. All patients were in a good general condition, in the age group of 50-60 years of which 12 had cervical carcinoma and 4 had bladder carcinoma.

Results: The median operative time was 180 min. The mean number of harvested pelvic iliac nodes was 14. All margins were tumor-free. The median postoperative hospital stay was 3 days. Three patients had postoperative complications; two had subacute intestinal obstruction and one had ureteric leak. The median follow-up was 15 months.

Conclusions: Our results have demonstrated the feasibility and oncological safety of performing anterior exenteration laparoscopically in advanced pelvic cancer patients with acceptable morbidity. Intermediate-term follow-up validates the adequacy of this procedure.

MeSH terms

  • Feasibility Studies
  • Female
  • Humans
  • Laparoscopy*
  • Length of Stay
  • Lymph Node Excision
  • Middle Aged
  • Neoplasm Recurrence, Local / surgery
  • Pelvic Exenteration / adverse effects
  • Pelvic Exenteration / methods*
  • Pelvic Neoplasms / surgery*
  • Retrospective Studies
  • Urinary Bladder Neoplasms / surgery
  • Uterine Cervical Neoplasms / surgery
  • Vaginal Neoplasms / surgery*